Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Anagenics Limited (AU:AN1)
ASX:AN1
Holding AU:AN1?
Track your performance easily
AN1 Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Anagenics Limited News
PremiumCompany Announcements
Anagenics Limited Announces Proposed Issue of 35 Million Securities
PremiumCompany Announcements
Anagenics Limited Eyes Growth Amid Strategic MovesPremiumCompany Announcements
Anagenics Limited’s Strategic Restructuring and Share IssuancePremiumCompany Announcements
Anagenics Completes Restructure, Reports Positive November Results
PremiumCompany Announcements
Anagenics Limited Gains Shareholder Support at AGM
PremiumCompany Announcements
Anagenics Limited Announces Director Resignation
PremiumCompany Announcements
Anagenics Limited Streamlines Operations for Profitability
PremiumCompany Announcements
Anagenics Limited Targets Profitability with New Business ModelOptions Prices
Currently, No data available
---
Ownership Overview
AN1 FAQ
What was Anagenics Limited’s price range in the past 12 months?
Currently, no data Available
What is Anagenics Limited’s market cap?
Anagenics Limited’s market cap is AU$3.69M.
When is Anagenics Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Anagenics Limited’s earnings last quarter?
Anagenics Limited released its earnings results on Aug 30, 2024. The company reported -AU$0.014 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.014.
Is Anagenics Limited overvalued?
According to Wall Street analysts Anagenics Limited’s price is currently Overvalued.
Does Anagenics Limited pay dividends?
Anagenics Limited does not currently pay dividends.
What is Anagenics Limited’s EPS estimate?
Anagenics Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Anagenics Limited have?
Currently, no data Available
What happened to Anagenics Limited’s price movement after its last earnings report?
Anagenics Limited reported an EPS of -AU$0.014 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Anagenics Limited?
Currently, no hedge funds are holding shares in AU:AN1
---
Anagenics Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
AU:AN1 Sentiment 100%
Sector Average 64%
Sector Average 64%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Fundamentals
Return on Equity
-125.53%
Trailing 12-Months
Asset Growth
-44.28%
Trailing 12-Months
Company Description
Anagenics Limited
Cellmid Ltd develops and sells diagnostic and therapeutic products for diseases such as cancer and chronic inflammatory conditions. Its principal activities are divided into Midkine Business and Consumer Health Business. The group is organized into two operating segments: Research and development of diagnostics and therapeutics; and Research, development, and marketing of hair growth products. The company derives most of its revenue from Consumer Health. It derives most of its geographical revenue from Japan.
---
Star Combo Pharma Ltd.
―
Botanix Pharmaceuticals Limited
―
IDT Australia Limited
―
Respiri Limited
―
Cynata Therapeutics Limited
―
---